Immunotherapy with Y90-radioembolization for metastatic colorectal cancer (iRE-C). Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) ...
Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting II. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results